References
- Sedin G, Bergquist C, Lindgren PG. Ovarian hyperstimulation syndrome in preterm infants. Pediatr Res. 1985;19:548–552.
- Vochem M. Ovarian hyperstimulation syndrome in preterm infants. Z Geburtshilfe Neonatol. 2002;206:156–160.
- Starzyk J, Wójcik M, Wojtyś J, et al. Ovarian hyperstimulation syndrome in newborns – a case presentation and literature review. Horm Res. 2009;71:60–64.
- Marinkovic M, Rasmussen M, Jones K. Feminizing changes in a prematurely born infant. Clin Pediatr. 2010;49:188–189.
- Altuntas N, Turkyilmaz C, Yuce O, et al. Preterm ovarian hyperstimulation syndrome presented with vaginal bleeding: a case report. J Pediatr Endocrinol Metabol. 2014;27:355–358.
- Halis H, Memur S, Korkmaz L, et al. Ovarian hyperstimulation syndrome treated by medroxyprogesterone acetate. J Pediatr Endocrinol Metabol. 2014;27:997–999.
- Esen I, Demirel F. Images in clinical medicine. Preterm ovarian hyperstimulation. N Engl J Med. 2015;372:2336.
- Durst MA, Wicklow B, Narvey M. Atypical case of preterm ovarian hyperstimulation syndrome. BMJ Case Rep. 2017;2017:1–4.
- Forest MG, Peretti E, Bertrand J. Hypothalamic-pituitary-gonadal relationships in man from birth to puberty. Clin Endocrinol. 1976;5:551–569.
- Forest MG, Sizonenko PC, Cathiard AM, et al. Hypophyso-gonadal function in humans during the first year of life. 1. Evidence for testicular activity in early infancy. J Clin Invest. 1974;53:819–828.
- Chellakooty M, Schmidt IM, Haavisto AM, et al. Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab. 2003;88:3515–3520.
- Greaves RF, Hunt RW, Chiriano AS, et al. Luteinizing hormone and follicle-stimulating hormone levels in extreme prematurity: development of reference intervals. Pediatrics. 2008;121:e574–e580.
- Kuiri-Hanninen T, Kallio S, Seuri R, et al. Postnatal developmental changes in the pituitary-ovarian axis in preterm and term infant girls. J Clin Endocrinol Metab. 2011;96:3432–3439.
- Pfeifer SBS, Dumesic D, Fossum G, et al. Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril. 2016;106:1634–1647.
- d'Alva CB, Serafini P, Motta E, et al. Absence of follicle-stimulating hormone receptor activating mutations in women with iatrogenic ovarian hyperstimulation syndrome. Fertil Steril. 2005;83:1695–1699.
- Budev MM, Arroliga AC, Falcone T. Ovarian hyperstimulation syndrome. Crit Care Med. 2005;33:S301–S306.
- Smits G, Olatunbosun O, Delbaere A, et al. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med. 2003;349:760–766.
- Vasseur C, Rodien P, Beau I, et al. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med. 2003;349:753–759.
- Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril. 2000;74:429–438.
- Shinkawa O, Furuhashi N, Fukaya T, et al. Changes of serum gonadotropin levels and sex differences in premature and mature infant during neonatal life. J Clin Endocrinol Metab. 1983;56:1327–1331.
- deSa DJ. Follicular ovarian cysts in stillbirths and neonates. Arch Dis Child. 1975;50:45–50.
- Bryant AE, Laufer MR. Fetal ovarian cysts: incidence, diagnosis and management. J Reprod Med. 2004;49:329–337.
- Kwak DW, Sohn YS, Kim SK, et al. Clinical experiences of fetal ovarian cyst: diagnosis and consequence. J Korean Med Sci. 2006;21:690–694.